Log in Start free →
Today’s CSR movers
SRE 4.1 ▲ 1.2
ES 3.0 ▲ 0.8
EIX 3.1 ▲ 0.8
AMZN 4.7 ▲ 0.1
GS 2.3 ▼ 0.8
WEC 2.6 ▼ 1.2
ETR 2.9 ▼ 1.2
C 2.8 ▼ 1.2
PCG 2.9 ▼ 1.2
FOX 2.4 ▼ 1.5
—
—
Health Care · NYSE NYSE · BMY

Bristol Myers Squibb

$60.16 -$0.57 -0.95% CLOSE 07.20.26 AFTER HOURS $60.24
Convergence score
3.6 / 5.0 BULLISH
+0.0 vs last report
Overall valuation
Undervalued
Aggregated across multiple horizons
Consensus target (12mo)
$62.39 +3.7%
Range $40.00 — $75.00
Sector
Health Care
NYSE · Tracked daily
Today's snapshot

Where the signals stand.

REPORT 07.20.26
UV Convergence Score
REPORT 07.20.26
3.6
/ 5.0
BULLISH
Consensus signal A
4.0
Consensus signal B
3.0
Consensus signal D
4.0
Rating trend signal
3.6
Analyst average
3.5
Multi-signal aggregate How CSR works →
Day Range
$60.02 – $61.35
52W Range
$42.52 – $62.89
Volume
8.1M
Avg Vol
11.8M
Mkt Cap
$122.85B
P/E
16.85
EPS (TTM)
$3.57
Div Yield
4.15%
Beta
0.23
Today's convergence

Convergence score sits at 3.6 with overall valuation reading as undervalued. Drivers across the horizons inform the aggregate. Open the deep dives for valuation, analyst, or financial detail.

Valuation
Undervalued
CSR direction
BULLISH
Last close
$60.16
Sector
Health Care
Valuation
Three horizons
UPDATED 07.20.26
Short term
0–3 MO
No target Moderate Buy
Medium term
3–12 MO
$61+1.8% Hold
Long term
12–36 MO
$96.25+60.0% Undervalued
Open valuation →
Analysts
Coverage & consensus
4 PANELS
Mean target (12mo)
$62.39 +3.7%
RANGE $40.00 — $75.00
Analyst consensus
Consensus rating Hold
Blended score 3.3 / 5
Analysts tracked 101
Open analysts →
Financials
Key metrics
LATEST
P/E
16.85
EPS (TTM)
$3.57
Mkt Cap
$122.85B
Div Yield
4.15%
Beta
0.23
52W Range
$42.52 – $62.89
Open financials →
Reports
Login for history

Sign in to view the historical report archive for this stock.

Log in →
Valuation breakdown

Three horizons, one consensus.

UPDATED 07.20.26
Short term
0–3 MO
Moderate Buy
Consensus target
No target available

Current analyst consensus rating from Barchart.

Medium term
3–12 MO
Hold
Consensus target
$61 +1.8%
RANGE $40 – $75
$40NOW $60.16$75

12-month analyst consensus target across covering brokerages.

Long term
12–36 MO
Undervalued
Consensus target
$96.25 +60.0%

UVStocks in-house sector-relative valuation model.

Signal breakdown

What’s driving the score.

EACH SIGNAL RATED 1.0 — 5.0
Top-level breakdown
Valuation: PE Ratio: 16.85PEG Ratio: -DE Ratio: -
Free Cash Flow: $9.85BPB Ratio: -PS Ratio: -Dividend: $0.63
Analyst coverage

Blended analyst consensus & targets.

4 PANELS · UPDATED 07.20.26
Analyst consensus RATING · SCORE · PANELS · ANALYSTS
Rating Blended score Panels Analysts
Hold 3.3 4 101
Price targets LOW · MEAN · MEDIAN · HIGH · UPSIDE
Coverage Low Mean Median High Upside
All panels $40.00 $62.39 $63.00 $75.00 +3.7%
Rating distribution STRONG BUY · BUY · HOLD · SELL · STRONG SELL
Coverage SB B H S SS
All panels 4 14 27 2 0
Rating trend CURRENT VS 1M / 2M / 3M
Period Rating Avg Analysts
Current Moderate Buy 3.63 30
1 Mo Ago Moderate Buy 3.61 31
2 Mo Ago Moderate Buy 3.61 31
3 Mo Ago Moderate Buy 3.61 31
Most recent analyst action LATEST DESK ACTION
Date
7/16/2026
Firm
Weiss Ratings
Action
Downgrade
Rating
Hold (C+) ➝ Hold (C)
Target
—
Related links
Financials

Full financial snapshot.

UPDATED 07.20.26
Quote snapshot 15 FIELDS
Prev Close
$60.74
Open
$60.76
Day Low
$60.02
Day High
$61.35
Bid
$60.18
Ask
$60.25
52W Low
$42.52
52W High
$62.89
50D Avg
$56.96
200D Avg
$54.69
Volume
8.1M
Avg Vol
11.8M
10D Avg Vol
10.7M
52W Change
30.09%
S&P 52W Change
18.27%
Valuation ratios 10 FIELDS
P/E (TTM)
16.85
P/E (Fwd)
9.71
PEG (Fwd)
1.58
P/S
2.53
P/B
6.12
Book Value
$9.83
EV/Revenue
3.28
EV/EBITDA
8.37
Mkt Cap
122.85B
Enterprise Val
158.83B
Profitability & returns 6 FIELDS
Profit Margin
15.01%
Gross Margin
71.98%
Operating Margin
33.04%
EBITDA Margin
39.14%
Return on Assets
10.69%
Return on Equity
38.73%
Growth 3 FIELDS
Revenue Growth (YoY)
2.60%
Earnings Growth (YoY)
9.20%
Earnings Growth (Q)
9.00%
Balance sheet & cash flow 11 FIELDS
Total Revenue
48.48B
EBITDA
18.97B
Total Cash
10.49B
Total Debt
46.43B
Cash / Share
$5.13
Revenue / Share
$23.82
Free Cash Flow
9.85B
Operating CF
13.31B
Debt / Equity
230.97
Current Ratio
1.42
Quick Ratio
1.18
Dividend 5 FIELDS
Fwd Dividend
2.52 (4.15%)
Dividend Yield
4.15%
Payout Ratio
70.03%
5Y Avg Yield
3.96%
Ex-Div Date
2026-07-02
Share statistics 7 FIELDS
Shares Out
2.04B
Float
2.04B
Shares Short
40.53M
% Short of Float
1.99%
Short Ratio
2.89
% Held Insiders
0.08%
% Held Institutions
83.79%
Calendar & events 5 FIELDS
Next Earnings
2026-07-30
Fiscal Year End
2025-12-31
Most Recent Qtr
2026-03-31
Last Split
1000000:951777
Split Date
2001-08-07
Company 2 FIELDS
Industry
Drug Manufacturers - General
Employees
32,500